CTAS vs HSIC · P/E 51, rev $11.26B vs P/E 24, rev $6.83B
Cintas Corporation (CTAS) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the CTAS and HSIC stock pages for the full models.
Not investment advice.